Cosmetic peptides

What is a peptide cream and what does it promise?

Peptides are short chains formed by linking a few amino acids together. A 2009 review divides the peptides used for aging skin into four groups: signal peptides, enzyme-inhibitor peptides, neurotransmitter-inhibiting peptides and carrier peptides. The review brings together controlled laboratory and human studies of these peptides. ^[1]

The two promises most often encountered in cosmetic products are these: reducing wrinkles by increasing collagen production (signal peptides) and softening expression lines by easing the contraction of facial muscles (“Botox-like” peptides). The best-known member of the second group is acetyl hexapeptide-8, and of the first group palmitoyl pentapeptide-4. ^{[6] [7]}

The main obstacle for peptides is the skin. According to a 2025 review, because of its water-loving structure and relatively large molecule, acetyl hexapeptide-8 passes only to a limited extent through the oily outer layer of the skin (stratum corneum); whether the peptide can reach neuromuscular junctions is uncertain. ^[6]

Does acetyl hexapeptide-8 reduce wrinkles?

Acetyl hexapeptide-8 (INCI name ACETYL HEXAPEPTIDE-8; also appears in the literature as acetyl hexapeptide-3) is a six-amino-acid peptide designed by sampling from the end of the SNAP-25 protein. SNAP-25 is part of the SNARE protein complex required for the neurotransmitter release that starts muscle contraction at nerve endings; the peptide is intended to disrupt formation of this complex. ^[6] In the 2002 study introducing the substance, the peptide suppressed neurotransmitter release in the laboratory with a potency similar to botulinum toxin A, but, as expected, with much lower efficacy. In the same study, an oil-in-water emulsion containing 10% peptide reduced wrinkle depth by up to 30% in 30 days in healthy female volunteers; the abstract does not give the number of participants or the comparison group. ^[2]

The next two studies do not agree with each other:

The author of the German study writes that the effect of the peptide could not be proven and that it therefore cannot be considered an alternative treatment to botulinum toxin. ^[4] This picture shows that a single positive study cannot be taken as general proof of effect for peptide creams.

What did palmitoyl pentapeptide-4 show?

Palmitoyl pentapeptide-4 (INCI name PALMITOYL PENTAPEPTIDE-4; pal-KTTKS) is a five-amino-acid peptide with a fatty acid attached, designed to provide an anti-wrinkle benefit by stimulating collagen production. ^[7]

The basis of human data for this substance is a single 2005 study: 93 white women aged 35–55 applied, for 12 weeks, a peptide-free moisturizer to one half of the face and, to the other half, the same moisturizer containing 3 parts per million (3 ppm) palmitoyl pentapeptide-4 (double-blind, placebo-controlled, left-right randomized). The peptide side showed significant improvement over placebo in fine lines and wrinkles, in both device-measured and expert-evaluator image analysis; participants also reported improvement in fine lines and the product was well tolerated. According to the PubMed record, the first author is affiliated with the research laboratory of a company that makes cosmetic products. ^[7]

The results reported in the study abstract are wrinkle image analysis and participant evaluation; skin collagen measurement is not reported. For this reason, the “increases collagen” claim is not considered directly shown by this study. Because of a single RCT and the company link, the evidence grade is limited to C.

Acetyl octapeptide-3 and other Botox-like peptides

Acetyl octapeptide-3, as its name suggests, is an eight-amino-acid peptide and is used in anti-wrinkle products. Published human data are very limited. In one study found, a dissolving microneedle patch containing acetyl octapeptide-3, a vitamin C derivative and another active ingredient was applied overnight around one eye of 24 healthy volunteers, and a placebo patch consisting only of hyaluronic acid around the other eye; at 28-day follow-up, more wrinkle improvement and no side effects were reported on the active-patch side. Most of the authors are employees of the company that developed the patch; because the patch contains more than one active ingredient, it cannot be distinguished which component caused the effect. ^[8]

Microneedles pierce the outer layer of the skin and increase peptide passage; in a laboratory study on pig skin, the amount of acetyl hexapeptide-3 passing through the skin in 24 hours was found to be more than 31 times higher after microneedle application than in untreated skin. ^[6] For this reason, patch results cannot be transferred to the effect of an ordinary cream.

What do peptide creams show overall?

A systematic review and meta-analysis published in 2026 brought together 19 randomized controlled trials (1,341 participants) examining oral and topical peptides in skin aging. Seventeen of the studies were with oral and only 2 with topical products; one of the topical studies was the 60-person acetyl hexapeptide-8 study above. The pooled effect on wrinkles was small (mean difference 0.27; 95% CI 0.01–0.52; p=0.04) and this effect was driven largely by oral peptides; the effect of topical peptides was smaller and not statistically significant. The authors note that, because of the scarcity of topical studies, the results mainly reflect oral peptides. ^[9]

Oral collagen peptides are a separate topic and are covered in their own guide:

Detailed guideCollagen: evidence, forms and limits→

Does a peptide cream replace Botox?

This claim is unproven. In a laboratory study by FDA researchers in the US, an oil-in-water emulsion containing 10% acetyl hexapeptide-8 was applied for 24 hours to hairless guinea pig skin and human skin taken from cadavers. Most of the peptide was recovered by washing from the skin surface; in human skin, 0.22% of the applied amount remained in the stratum corneum and 0.01% in the epidermis, and no peptide was detected in the dermis or in the fluid beneath the skin. ^[5]

The 2025 review writes that how and to what extent the peptide suppresses muscle contraction when applied to the skin is not fully understood, and that more research is needed to confirm its use as an alternative to injection treatments. ^[6] The author of the 19-person split-face study above also concluded that the peptide cannot be considered an alternative to botulinum toxin. ^[4]

Are cosmetic peptides safe?

In controlled studies with peptides applied to the skin, no serious side effects were reported: in the 93-woman palmitoyl pentapeptide-4 study the product was well tolerated, and in the 19-person acetyl hexapeptide-8 study no allergic reaction or irritation was seen. ^{[7] [4]} In the 2026 meta-analysis too, no serious side effects were observed with topical or oral peptide use. ^[9]

The risk picture changes when the same peptides are injected. In a case reported from China in 2021, a 45-year-old woman was injected with acetyl hexapeptide-8 in the forehead and temples; one week later, redness, nodules and abscesses developed at the injection sites. Culture from the pus grew Mycobacterium abscessus, and the lesions regressed only with two-antibiotic treatment lasting 5 months. The authors state that this case is the first report of this infection after acetyl hexapeptide-8 injection and that it can easily be confused with an ordinary bacterial infection. ^[10] The 2025 review also cites this case and notes that if a peptide passes in significant amounts into the deep layers of the skin and alters bodily functions, it can no longer be considered a cosmetic product. ^[6]

For general risks of peptides used by injection: Peptide side effects

Copper peptides: GHK-Cu

GHK-Cu, which appears in ingredient lists under the INCI name COPPER TRIPEPTIDE-1, is one of the most frequently used peptides in cosmetics; however, because of its evidence base and its sale in injectable form as a “research peptide”, it is addressed separately:

Detailed guideGHK-Cu serums and creams: evidence and limits→ Detailed guideGHK-Cu: copper peptide, evidence and legal status→

How are peptide creams regulated?

European Union

The EU Cosmetic Products Regulation No 1223/2009 defines a cosmetic as a substance or mixture applied to the external parts of the human body (epidermis, hair and body hair, nails, lips, external genital organs) or to the teeth and the mucous membranes of the mouth, with a view exclusively or mainly to cleaning, perfuming, changing appearance, protecting, keeping in good condition or correcting body odors. Cosmetic products are notified electronically to the Commission before being placed on the market; Article 20 of the Regulation prohibits the use of text, names, trademarks and images in labeling, promotion and advertising that imply characteristics or functions the product does not have. ^[12]

In CosIng, the European Commission’s cosmetic ingredient database, ACETYL HEXAPEPTIDE-8 is registered as an ingredient with moisturizing and skin conditioning functions; no provision relating to the Regulation’s annexes or opinion of the scientific committee (SCCS) appears in the record. CosIng is an information database with no legal force; the presence of an ingredient on the list does not imply approval, and only the Regulation and its annexes determine under which conditions ingredients may be used. ^[11]

United States

According to the FDA, a product intended only to make lines and wrinkles less noticeable by moisturizing is a cosmetic; products intended to affect the structure or function of the body, such as removing wrinkles or increasing the skin’s collagen production, are considered drugs (or medical devices). Cosmetics do not require FDA approval before going on the market; drugs require approval for both safety and efficacy. The FDA states that it is concerned about anti-wrinkle products marketed as cosmetics that claim a structure or function effect on the skin. ^[14]

What is the status of peptide creams in Türkiye?

Status in Türkiye

Class

Cosmetic product; notification before placing on the market, not a license ^[13]

Supervising authority

TİTCK (Turkish Medicines and Medical Devices Agency) ^[13]

Out of scope

Products intended to be injected, swallowed or placed inside the body ^[13]

The Cosmetic Products Regulation (Kozmetik Ürünler Yönetmeliği) dated May 8, 2023 uses a cosmetic definition harmonized with the EU Regulation, and the TİTCK enforces it. Cosmetic products can be placed on the market only on condition that a “responsible person” established in the country is appointed (Art. 6). The responsible person has a safety assessment carried out before the product is placed on the market and has a safety assessment report prepared (Art. 13); the product information file contains evidence of the claimed effect where justified by the nature or effect of the product (Art. 14), and the product is notified to the Agency through the national electronic database (Art. 16). Article 23 of the Regulation prohibits the use of text, names and trademarks in labeling, promotion and advertising that imply characteristics or functions the product does not have. The Regulation does not cover substances and mixtures intended to be ingested, inhaled, injected or implanted inside the body (Art. 2). ^[13] For this reason, injectable “peptide” products are not cosmetics; their status is assessed under medicines legislation. This page is not legal advice.

For the legal framework of injectable peptides: Are peptides legal?

Evidence table: claim, population and limits

Limits of this guide

This page summarizes published human and laboratory studies on cosmetic peptides and official regulations. It does not recommend products, brands, concentrations or frequency of use. Most studies are small, short-term and manufacturer-linked; the content and formulation of products differ greatly from one another, so the result of a single study cannot be transferred to every “peptide cream” on the market. The information is valid as of October 2026.